Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 43 Results

Intervention Indication Therapeutic Area Year Actions
Selinexor for advanced or recurrent endometrial cancer - maintenance therapy Selinexor (KPT-330; Xpovio) Endometrial cancer Female Reproductive Cancer 2020 View  |  Download
Tisotumab vedotin for recurrent or metastatic cervical cancer Tisotumab vedotin (HuMax-TF-ADC) Cervical cancer Female Reproductive Cancer 2019 View  |  Download
Veliparib in addition to carboplatin and paclitaxel for epithelial ovarian, fallopian tube, or primary peritoneal cancer Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2018 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications